Targeting Notch1 and proteasome as an effective strategy to suppress T-cell lymphoproliferative neoplasms

about

High KIF2A expression predicts unfavorable prognosis in diffuse large B cell lymphoma.Combining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatments.

P2860

Q36405966-383C10F9-493C-45D7-AE8E-55CF773CC9EA Q37708989-E935AE87-6641-4DA5-A9AE-708FB64CC9FA

P2860

Targeting Notch1 and proteasome as an effective strategy to suppress T-cell lymphoproliferative neoplasms

Item

http://www.wikidata.org/entity/Q36020893

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Targeting Notch1 and proteasom ...... lymphoproliferative neoplasms

@ast

Targeting Notch1 and proteasom ...... lymphoproliferative neoplasms

@en

type

Item

label

Targeting Notch1 and proteasom ...... lymphoproliferative neoplasms

@ast

Targeting Notch1 and proteasom ...... lymphoproliferative neoplasms

@en

prefLabel

Targeting Notch1 and proteasom ...... lymphoproliferative neoplasms

@ast

Targeting Notch1 and proteasom ...... lymphoproliferative neoplasms

@en

P1476

Targeting Notch1 and proteasom ...... lymphoproliferative neoplasms

@en

P2093

Hesham M Amin

http://www.w3.org/2001/XMLSchema#string

Hong Liu

http://www.w3.org/2001/XMLSchema#string

Lujun Yang

http://www.w3.org/2001/XMLSchema#string

Mengqi Xu

http://www.w3.org/2001/XMLSchema#string

Rong Teng

http://www.w3.org/2001/XMLSchema#string

Shuangfeng Zhang

http://www.w3.org/2001/XMLSchema#string

Suraj Konnath George

http://www.w3.org/2001/XMLSchema#string

Wenyu Shi

http://www.w3.org/2001/XMLSchema#string

Xiaoping Sun

http://www.w3.org/2001/XMLSchema#string

Xuefen You

http://www.w3.org/2001/XMLSchema#string

P2860

Notch1 augments NF-kappaB activity by facilitating its nuclear retention

TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms

Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis

Aberrant rel/nfkb genes and activity in human cancer

The canonical Notch signaling pathway: unfolding the activation mechanism.

Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia

The stress-activated protein kinase subfamily of c-Jun kinases

Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma.

Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma.

United States Food and Drug Administration approval summary: bortezomib for the treatment of progressive multiple myeloma after one prior therapy.

P304

14953-14969

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.3621

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275052139

http://www.w3.org/2001/XMLSchema#string

P698

25879451

http://www.w3.org/2001/XMLSchema#string

P932

4558128

http://www.w3.org/2001/XMLSchema#string

Targeting Notch1 and proteasome as an effective strategy to suppress T-cell lymphoproliferative neoplasms

about

P2860

P2860

Targeting Notch1 and proteasome as an effective strategy to suppress T-cell lymphoproliferative neoplasms

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932